Back to ACAD

MEITAV INVESTMENT HOUSE LTD → ACAD

MEITAV INVESTMENT HOUSE LTD ACAD Position History

Acadia Pharmaceuticals Inc. • Healthcare

Quarters held
2
Latest value
$87.1M
Q3 2026
Peak value
$87.1M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$77.1M
Q3 2026$87.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$87.1M494.7K——
Q2 2026$77.1M439.7K——

Other funds holding ACAD

Other MEITAV INVESTMENT HOUSE LTD positions

VGES

VANGUARD INDEX FDS

$2B
VGES

VANGUARD INDEX FDS

$1.7B
ETHA

INVESCO EXCH TRADED FD TR II

$1.3B
SPY

STATE STR SPDR S&P 500 ETF T

$1.2B
SPY

STATE STR SPDR S&P 500 ETF T

$1.1B
ETHA

INVESCO EXCH TRADED FD TR II

$1.1B
SPY

TATE STR SPDR S&P 500 ETF T

$1B
SPY

SPDR S&P 500 ETF TR

$933.6M